Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00830037 · ClinicalTrials.gov registry record · Phase 4
A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease
A Phase 4 study, sponsored by Indiana University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 136
- Enrollment target
NCT00830037 is a Phase 4 study that was terminated before completion, run by Indiana University. The registered enrollment target is 136 participants.
The verdict
NCT00830037, a Phase 4 study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 136 participants
- Enrollment target
Study Summary
The long-term goal is to assess the fall in kidney function measured by glomerular filtration rate (GFR) when patients with chronic kidney disease (CKD) are exposed to intravenous iron (IVIR). We hypothesize that in subjects with mild to moderate CKD, infusion of intravenous iron (IVIR), will generate oxidative stress and cause an inflammatory response that will be associated with a more rapid decline in glomerular filtration rate (GFR) compared to oral iron.
Interventions
- DRUG Ferrous Sulfate
- DRUG IV Iron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2008-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00830037
The ClinicalTrials.gov registry entry for NCT00830037 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ferrous Sulfate is the first listed.
NCT00830037 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00830037 about?
NCT00830037 is a clinical study titled "A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease". The long-term goal is to assess the fall in kidney function measured by glomerular filtration rate (GFR) when patients with chronic kidney disease (CKD) are exposed to intravenous iron (IVIR). We hypothesize that in subjects with mild to moderate CKD, infusion of intravenous iron (IVIR), will genera...
What is the current status of trial NCT00830037?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 136 participants. The study started on 2008-08.
What interventions are being tested in trial NCT00830037?
The interventions under investigation include: Ferrous Sulfate (DRUG), IV Iron (DRUG).
Who is sponsoring clinical trial NCT00830037?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.